Combinatorial immune biomarkers of efficacy on buparlisib and paclitaxel in patients with SCCHN: BERIL-1 sub-analysis. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback